Bioengineered organs are no longer just structural substitutes. A review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) platforms—living ...
As the field of bioengineering continues to advance, scientists are making significant strides in growing organs for transplants. Among the most promising developments is the growth of lungs in the ...
BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (CDNA) and Miromatrix Medical Inc. (MIRO) -- today announced an exclusive partnership aimed at advancing the ...
United Therapeutics aims to expand its portfolio of organ manufacturing platforms with the $91 million purchase of xenotransplant developer Miromatrix Medical. The deal shakes out to a price of $3.25 ...
SAN DIEGO--(BUSINESS WIRE)--Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing ...